To test the effects of XO inhibition by febuxostat at an established hypertension stage, febuxostat was administered to DOCA-salt rats as a short-term treatment for 14 days after full development of mineralocorticoid hypertension was obtained (day 21 of DOCA-salt hypertension). Here, XDH is linked to Hypertension.